Cardiovascular

UNTOUCHED: Understanding Outcomes with the EMBLEMTM S-ICD in Primary Prevention Patients with Low Ejection Fraction

Boston Scientific

About the trial:

Full title:

UNTOUCHED: Understanding Outcomes with the EMBLEMTM S-ICD in Primary Prevention Patients with Low Ejection Fraction

Purpose of the trial:

The main objective of this study is to determine the 18-month incidence of inappropriate shocks in subjects implanted with the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) for primary prevention of sudden cardiac death. The incidence of inappropriate S-ICD shocks will be compared to the incidence of inappropriate shocks observed in the MADIT RIT study.

Researchers:

Principal Investigator:

Erik Altman, MD

Secondary Investigator:

Derek Altman, MD

Coordinators:

Locations:

Staten Island University Hospital

  • 475 Seaview Ave
    Staten Island, NY 10305

Dept of OB/GYN Urogynecology

  • 865 Northern Blvd
    Great Neck, NY 11021

ClinicalTrials.gov full clinical trial description
<